AU561077B2 – Linoleic +alpha-linolenic acids
– Google Patents
AU561077B2 – Linoleic +alpha-linolenic acids
– Google Patents
Linoleic +alpha-linolenic acids
Info
Publication number
AU561077B2
AU561077B2
AU23765/84A
AU2376584A
AU561077B2
AU 561077 B2
AU561077 B2
AU 561077B2
AU 23765/84 A
AU23765/84 A
AU 23765/84A
AU 2376584 A
AU2376584 A
AU 2376584A
AU 561077 B2
AU561077 B2
AU 561077B2
Authority
AU
Australia
Prior art keywords
alpha
metabolites
linoleic
disease
linolenic acids
Prior art date
1983-02-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU23765/84A
Other versions
AU2376584A
(en
Inventor
David Frederick Horrobin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Efamol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1983-02-01
Filing date
1984-01-25
Publication date
1987-04-30
1984-01-25
Application filed by Efamol Ltd
filed
Critical
Efamol Ltd
1984-08-02
Publication of AU2376584A
publication
Critical
patent/AU2376584A/en
1987-04-30
Application granted
granted
Critical
1987-04-30
Publication of AU561077B2
publication
Critical
patent/AU561077B2/en
1995-07-27
Assigned to SCOTIA HOLDINGS PLC
reassignment
SCOTIA HOLDINGS PLC
Alteration of Name(s) in Register under S187
Assignors: EFAMOL LIMITED
2004-01-25
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
A61K35/56—Materials from animals other than mammals
A61K35/60—Fish, e.g. seahorses; Fish eggs
A—HUMAN NECESSITIES
A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
A61K31/19—Carboxylic acids, e.g. valproic acid
A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K36/18—Magnoliophyta (angiosperms)
A61K36/185—Magnoliopsida (dicotyledons)
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P11/00—Drugs for disorders of the respiratory system
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P13/00—Drugs for disorders of the urinary system
A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P15/00—Drugs for genital or sexual disorders; Contraceptives
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P25/00—Drugs for disorders of the nervous system
A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P27/00—Drugs for disorders of the senses
A61P27/16—Otologicals
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P3/00—Drugs for disorders of the metabolism
A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P37/00—Drugs for immunological or allergic disorders
A61P37/08—Antiallergic agents
Abstract
A pharmaceutical or dietary composition for use in the treatment of atopic disorders, including eczema, asthma, allergies (especially allergic rhinitis), migraine and disorders associated with atopy including Crohn’s disease, ulcerative colitis, otitis media, nephrotic syndrome, or benign breast disease, or breast or other cancer, or diabetes, or alcoholism, comprising effective amounts of one or more of the metabolites of linoleic acid (GLA, DGLA, AA, 22:4n-6 or 22:5n-6) and one or more of the metabolites of alpha -linolenic acid (18:4n-3, 20:4n-3, 20:5n-3, 22:5n-3 or 22:6n-3) as such or in the form of an ester, salt, amide or other derivative convertible in the body thereto alone or in an acceptable pharmaceutical carrier or diluent.
AU23765/84A
1983-02-01
1984-01-25
Linoleic +alpha-linolenic acids
Ceased
AU561077B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
GB8302708
1983-02-01
GB838302708A
GB8302708D0
(en)
1983-02-01
1983-02-01
Pharmaceutical and dietary composition
Publications (2)
Publication Number
Publication Date
AU2376584A
AU2376584A
(en)
1984-08-02
AU561077B2
true
AU561077B2
(en)
1987-04-30
Family
ID=10537278
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU23765/84A
Ceased
AU561077B2
(en)
1983-02-01
1984-01-25
Linoleic +alpha-linolenic acids
Country Status (10)
Country
Link
US
(4)
US4681896A
(en)
EP
(4)
EP0440308B1
(en)
JP
(1)
JPS59152324A
(en)
AT
(4)
ATE113836T1
(en)
AU
(1)
AU561077B2
(en)
CA
(1)
CA1227429A
(en)
DE
(5)
DE3485664D1
(en)
GB
(1)
GB8302708D0
(en)
HK
(4)
HK2294A
(en)
IE
(1)
IE65028B1
(en)
Cited By (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU587625B2
(en)
*
1985-07-04
1989-08-24
Scotia Holdings Plc
Pharmaceutical and dietary composition
AU595012B2
(en)
*
1986-03-21
1990-03-22
Scotia Holdings Plc
Iron – containing composition and method for treatment of cancer
AU608571B2
(en)
*
1987-03-09
1991-04-11
Efamol Holdings Plc
Composition and method for treatment of peptic ulcers
Families Citing this family (109)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB8302708D0
(en)
*
1983-02-01
1983-03-02
Efamol Ltd
Pharmaceutical and dietary composition
JPS59172416A
(en)
*
1983-03-18
1984-09-29
Terumo Corp
Fat transfusion solution
GB8319073D0
(en)
*
1983-07-14
1983-08-17
Efamol Ltd
Fatty acid compositions
GB8326130D0
(en)
*
1983-09-29
1983-11-02
Efamol Ltd
Topical preparations containing tars and fatty acids
CA1239587A
(en)
*
1983-10-24
1988-07-26
David Rubin
Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
AU4595985A
(en)
*
1984-08-10
1986-02-13
Sentrachem Limited
Cancer treatment
GB8506027D0
(en)
*
1985-03-08
1985-04-11
Efamol Ltd
Pharmaceutical & dietary compositions
GB8507058D0
(en)
*
1985-03-19
1985-04-24
Efamol Ltd
Pharmaceutical & dietary compositions
FR2581310B1
(en)
*
1985-05-02
1988-09-23
Natura Medica Laboratoires
THERAPEUTIC COMPOSITION COMPRISING A-LINOLENIC ACID AND A COMPOUND CAPABLE OF PROMOTING ACID THROUGH THE CELL MEMBRANE AND PLANT EXTRACT COMPRISING THE ACID AND THE COMPOUND
JPH0648970B2
(en)
*
1985-08-13
1994-06-29
旭電化工業株式会社
Method for producing sterile oil and fat composition
GB8522670D0
(en)
*
1985-09-13
1985-10-16
Efamol Ltd
Drug treatments
GB8524276D0
(en)
*
1985-10-02
1985-11-06
Efamol Ltd
Pharmaceutical & dietary compositions
GB8524275D0
(en)
*
1985-10-02
1985-11-06
Efamol Ltd
Pharmaceutical & dietary compositions
GB8601915D0
(en)
*
1986-01-27
1986-03-05
Efamol Ltd
Pharmaceutical compositions
DE3615710A1
(en)
*
1986-05-09
1987-11-26
Hoechst Ag
PREPARATIONS FOR THE SYNTHESIS OF PROSTAGLANDINES AND HYDROXY FATTY ACIDS IN BIOLOGICAL SYSTEMS
DE3863678D1
(en)
*
1987-04-27
1991-08-22
Efamol Holdings
PHARMACEUTICAL PREPARATIONS CONTAINING LITHIUM SALTS.
US5252333A
(en)
*
1987-04-27
1993-10-12
Scotia Holdings Plc
Lithium salt-containing pharmaceutical compositions
GB8714772D0
(en)
*
1987-06-24
1987-07-29
Efamol Ltd
Essential fatty acid compositions
US5198468A
(en)
*
1987-06-24
1993-03-30
Efamol Holdings Plc
Essential fatty acid composition
IT1223290B
(en)
*
1987-07-27
1990-09-19
Indena Spa
VASOCINETIC ACTION POLYUNSATURATED ACIDS AND RELATED PHARMACEUTICAL AND COSMETIC FORMULATIONS
ZA885473B
(en)
*
1987-08-07
1989-03-29
Century Lab Inc
Free fatty acids for treatment of diabetes mellitus
US5034415A
(en)
*
1987-08-07
1991-07-23
Century Laboratories, Inc.
Treatment of diabetes mellitus
DE3734147C2
(en)
*
1987-10-09
1998-10-29
Braun Melsungen Ag
Isotonic omega-3 fatty acid-containing fat emulsion and its use
WO1990014824A1
(en)
*
1988-01-14
1990-12-13
Anders Frithz
Use of essential fatty acids for the preparation of a drug for the treatment of eczema
GB8806737D0
(en)
*
1988-03-22
1988-04-20
Efamol Holdings
Therapeutic composition & method
US4963368A
(en)
*
1988-04-18
1990-10-16
Nabisco Brands, Inc.
Oxidoreductase enzyme stabilized highly unsaturated fatty acids and derivatives of such acids
GB8813766D0
(en)
*
1988-06-10
1988-07-13
Efamol Holdings
Essential fatty acid compositions
GB8819110D0
(en)
*
1988-08-11
1988-09-14
Norsk Hydro As
Antihypertensive drug & method for production
IE63225B1
(en)
*
1988-09-13
1995-04-05
Efamol Holdings
Use of fatty acids in the treatment of myalgic encephalomyelitis
US5059622A
(en)
*
1989-08-29
1991-10-22
Biosyn, Inc.
Method for reducing blood pressure levels in hypertensive persons
DE3901048A1
(en)
*
1989-01-14
1990-07-19
Chimicasa Gmbh
ANTIKACHECTIKUM
DE69025787T2
(en)
*
1989-04-04
1996-10-31
Beiersdorf Ag
Prophylaxis for atopy
DE3910761A1
(en)
*
1989-04-04
1990-10-11
Bodo Dr Med Melnik
Composition for atopy prophylaxis
US5591446A
(en)
*
1989-04-04
1997-01-07
Beiersdorf, A.G.
Methods and agents for the prophylaxis of atopy
DE3910760A1
(en)
*
1989-04-04
1990-10-11
Bodo Dr Med Melnik
NEW USE OF KNOWN SUBSTANCES AND METHOD FOR THE PRODUCTION OF SUITABLE PREPARATIONS
GB8920228D0
(en)
*
1989-09-07
1989-10-18
Efamol Holdings
Fatty acid therapy
US5407957A
(en)
*
1990-02-13
1995-04-18
Martek Corporation
Production of docosahexaenoic acid by dinoflagellates
US5302617A
(en)
*
1990-04-27
1994-04-12
Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio
Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
DK0454429T3
(en)
*
1990-04-27
1997-03-17
R Tech Ueno Ltd
Use of 15-dehydroxy-16-oxoprostaglandin derivatives for the treatment of allergic diseases
GB9012651D0
(en)
*
1990-06-06
1990-07-25
Efamol Holdings
Essential fatty acid treatment
JP2731035B2
(en)
*
1991-01-24
1998-03-25
マーテック・コーポレイション
Microbial oil mixtures and uses thereof
GB9111900D0
(en)
*
1991-06-03
1991-07-24
Efamol Holdings
Fatty acid compositions
US5212126A
(en)
*
1991-06-10
1993-05-18
Dresser Industries, Inc.
Aluminum resistant refractory and method
WO1993020717A2
(en)
*
1992-04-13
1993-10-28
Research Corporation Technologies, Inc.
Reducing gastrointestinal irritation in infant nutrition
GB9211229D0
(en)
*
1992-05-27
1992-07-08
Efamol Holdings
Fatty acid treatment
FR2691616B1
(en)
*
1992-05-27
1995-06-09
Thorel Jean Noel
NUTRITIONAL BIO-VECTORS.
GB9224809D0
(en)
*
1992-11-26
1993-01-13
Scotia Holdings Plc
Schizophrenia
DE4304394A1
(en)
*
1993-02-13
1993-09-02
Fresenius Ag
Prepn. for nourishment of oncological patients – comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
US20050027004A1
(en)
*
1993-06-09
2005-02-03
Martek Biosciences Corporation
Methods of treating senile dementia and Alzheimer’s diseases using docosahexaenoic acid and arachidonic acid compositions
GB9403855D0
(en)
*
1994-03-01
1994-04-20
Scotia Holdings Plc
Fatty acid derivatives
US5780451A
(en)
*
1994-04-01
1998-07-14
Abbott Laboratories
Nutritional product for a person having ulcerative colitis
US5952314A
(en)
*
1994-04-01
1999-09-14
Demichele; Stephen Joseph
Nutritional product for a person having ulcerative colitis
WO1995026646A1
(en)
*
1994-04-01
1995-10-12
Abbott Laboratories
Nutritional product for treatment of ulcerative colitis and use thereof
AU711482B2
(en)
*
1994-06-28
1999-10-14
Scotia Holdings Plc
Compositions for treatment of diabetic complications
JP3770628B2
(en)
*
1994-08-09
2006-04-26
サントリー株式会社
Prevention and amelioration of medical symptoms through delayed allergic reaction
US5578576A
(en)
*
1994-09-02
1996-11-26
Dalhousie University
Method and composition for treating intestinal wounds or ulcers
EP0711503A3
(en)
*
1994-11-14
1997-11-26
Scotia Holdings Plc
Milk fortified with GLA and/or DGLA
AU5346296A
(en)
1995-04-17
1996-11-07
Japan As Represented By Director-General Of Agency Of Industrial Science And Technology
Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fa tty acids by using the microorganisms
US5962030A
(en)
1997-03-07
1999-10-05
Akesis Pharmaceuticals, Inc.
Dietary supplement and method of treatment for diabetic control
US7015249B1
(en)
1997-12-12
2006-03-21
Purdue Research Foundation
Methods and compositions for treating diabetes
WO1999029317A1
(en)
*
1997-12-12
1999-06-17
Purdue Research Foundation
Methods and compositions for treating diabetes
US7138431B1
(en)
*
1998-02-23
2006-11-21
Wake Forest University
Dietary control of arachidonic acid metabolism
IL125731A
(en)
1998-08-11
2004-06-20
Zvi Yehuda
Acylates which are products of neurotransmitters and essential fatty acids, pharmaceutical compositions containing them, use of such acylates in the manufacture of medicaments, and method for treating nervous diseases in non-human animals
US6852760B1
(en)
1998-09-17
2005-02-08
Akesis Pharmaceuticals, Inc.
Compositions and methods for treatment for glucose metabolism disorders
US6376549B1
(en)
*
1998-09-17
2002-04-23
Akesis Pharmaceuticals, Inc.
Metforimin-containing compositions for the treatment of diabetes
KR20000046633A
(en)
*
1998-12-31
2000-07-25
성재갑
Composition for treatment of atopic dermatonosis
US6440931B1
(en)
1999-02-23
2002-08-27
Natural Corporation
Conjugated linoleic acid in treatment and prophylaxis of diabetes
WO2001015552A1
(en)
*
1999-08-30
2001-03-08
Ocean Nutrition Canada Ltd.
A nutritional supplement for lowering serum triglyceride and cholesterol levels
US6998501B1
(en)
*
1999-08-30
2006-02-14
Ocean Nutrition Canada Limited
Nutritional supplement for lowering serum triglyceride and cholesterol levels
US6426367B1
(en)
*
1999-09-09
2002-07-30
Efa Sciences Llc
Methods for selectively occluding blood supplies to neoplasias
US6340705B1
(en)
1999-09-10
2002-01-22
Monsanto Technology, Llc
Use of α-linolenic acid metabolites for treatment or prevention of cancer
CA2301158A1
(en)
*
2000-03-24
2001-09-24
Stephen J. Allen
Screening methods for compounds useful for modulating lipid metabolism in disease
GB0111282D0
(en)
*
2001-05-09
2001-06-27
Laxdale Ltd
Potentiation of therapeutic effects of fatty acids
CA2449199A1
(en)
*
2001-05-30
2002-12-05
Laxdale Limited
Coenzyme q and eicosapentaenoic acid (epa)
GB0113348D0
(en)
2001-06-01
2001-07-25
Mars Uk Ltd
Skin diet
US6853781B2
(en)
*
2001-08-13
2005-02-08
Sumitomo Electric Lightwave Corp.
Air blown fiber (ABF) cable with low composite coefficient of thermal expansion
WO2003017945A2
(en)
*
2001-08-24
2003-03-06
Martek Biosciences Boulder Corporation
Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
US7098352B2
(en)
*
2001-11-16
2006-08-29
Virtus Nutrition Llc
Calcium salt saponification of polyunsaturated oils
JP2005525311A
(en)
*
2002-01-04
2005-08-25
イヴァックス リサーチ インコーポレイテッド
Drug delivery system for sustained delivery of glipizide
NZ535549A
(en)
*
2002-03-08
2006-02-24
Monsanto Technology Llc
Treatment and prevention of inflammatory disorders
EP2295529B2
(en)
*
2002-07-11
2022-05-18
Basf As
Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
SE0202188D0
(en)
*
2002-07-11
2002-07-11
Pronova Biocare As
A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
US20040208939A1
(en)
*
2003-04-18
2004-10-21
Barry Sears
Novel dietary compositions to reduce inflammation
US7424812B2
(en)
*
2003-05-16
2008-09-16
Stanton Concepts Inc.
Multiple function lock
CA2436650A1
(en)
*
2003-08-06
2005-02-06
Naturia Inc.
Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US7759507B2
(en)
*
2003-09-05
2010-07-20
Abbott Laboratories
Lipid system and methods of use
JP4721642B2
(en)
*
2004-01-20
2011-07-13
サントリーホールディングス株式会社
Preventive or ameliorating agent for liver diseases associated with liver damage
CA2564592C
(en)
*
2004-04-29
2013-05-28
Abbott Laboratories
Compositions for improving breast health in women
US8663679B2
(en)
2004-04-29
2014-03-04
Abbott Laboratories
Compositions for improving breast health in women
AU2005241033A1
(en)
*
2004-04-30
2005-11-17
Virtus Nutrition Llc
Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
US8092839B2
(en)
*
2004-12-13
2012-01-10
Swing Aerobics Licensing, Inc.
Medicament for treatment of cancer and other diseases
US8431165B2
(en)
*
2004-12-13
2013-04-30
Swing Aerobics Licensing, Inc.
Medicament for treatment of cancer and other diseases
CA2599112C
(en)
2005-02-14
2013-10-22
Suntory Limited
Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
JP2006306813A
(en)
*
2005-04-28
2006-11-09
Suntory Ltd
Mast cell increase inhibitor
JP2006306812A
(en)
*
2005-04-28
2006-11-09
Suntory Ltd
Acidocyte infiltration inhibitor
EP1957039A2
(en)
*
2005-12-09
2008-08-20
Drugtech Corporation
Intravenous essential fatty acid emulsion
US8343753B2
(en)
*
2007-11-01
2013-01-01
Wake Forest University School Of Medicine
Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US9006288B2
(en)
*
2009-01-12
2015-04-14
Biokier, Inc.
Composition and method for treatment of diabetes
AR080596A1
(en)
2009-02-16
2012-04-25
Giuliani International Inc
RENTAL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
GB0907413D0
(en)
2009-04-29
2009-06-10
Equateq Ltd
Novel methods
CN102370720A
(en)
*
2010-08-27
2012-03-14
翟长民
Desensitization paste for treating rhinitis
US8293790B2
(en)
2011-10-19
2012-10-23
Dignity Sciences Limited
Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
EA030762B1
(en)
2012-02-09
2018-09-28
Ногра Фарма Лимитед
Methods of treating fibrosis
CN102641370A
(en)
*
2012-05-02
2012-08-22
李承平
Pharmaceutical composition ointment for treating rhinitis
JP2017516823A
(en)
*
2014-06-04
2017-06-22
ディグニティ サイエンシス リミテッド
Pharmaceutical compositions containing DGLA and uses thereof
CA3027867A1
(en)
*
2016-01-07
2017-07-13
Ds Biopharma Limited
Pharmaceutical compositions comprising dgla and use of same
CA3014575A1
(en)
*
2016-02-26
2017-08-31
Nogra Pharma Limited
Methods of treating lactose intolerance
WO2017197076A1
(en)
2016-05-11
2017-11-16
University Of Southern California
Fasting mimicking diet (fmd) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.
US10639313B2
(en)
2017-09-01
2020-05-05
Ndsu Research Foundation
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
Family Cites Families (10)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
GB1476624A
(en)
*
1973-05-30
1977-06-16
Cepbepe
Tranquiliser medicaments
US4058594A
(en)
*
1974-04-25
1977-11-15
John Williams
Immuno-suppressive agents
US3950547A
(en)
*
1974-08-26
1976-04-13
Syntex (U.S.A.) Inc.
Dietary composition and methods of preparing
US4444755A
(en)
*
1978-01-23
1984-04-24
Efamol Limited
Treatment for skin disorders
IE47777B1
(en)
*
1978-01-23
1984-06-13
Efamol Ltd
Pharmaceutical and dietary composition comprising gamma-linolenic acids
GB2033745B
(en)
*
1978-05-26
1983-08-17
Wellcome Found
Fatty acid and derivatives thereof for use in treatment or prophylaxis of thromboembolic conditions
IE49783B1
(en)
*
1979-05-18
1985-12-11
Efamol Ltd
Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB2134782B
(en)
*
1982-09-22
1987-03-04
Sentrachem Ltd
Anti-cancer compositions containing higher fatty acids
GB8302708D0
(en)
*
1983-02-01
1983-03-02
Efamol Ltd
Pharmaceutical and dietary composition
US4467821A
(en)
*
1983-07-07
1984-08-28
Conair Corporation
Actuator control for retractable bristle brushes
1983
1983-02-01
GB
GB838302708A
patent/GB8302708D0/en
active
Pending
1984
1984-01-24
AT
AT91200355T
patent/ATE113836T1/en
not_active
IP Right Cessation
1984-01-24
DE
DE8484300410T
patent/DE3485664D1/en
not_active
Expired – Fee Related
1984-01-24
DE
DE3486339T
patent/DE3486339T2/en
not_active
Expired – Fee Related
1984-01-24
AT
AT91200356T
patent/ATE109977T1/en
active
1984-01-24
AT
AT84300410T
patent/ATE75143T1/en
not_active
IP Right Cessation
1984-01-24
EP
EP91200355A
patent/EP0440308B1/en
not_active
Expired – Lifetime
1984-01-24
EP
EP91200354A
patent/EP0440307B1/en
not_active
Expired – Lifetime
1984-01-24
AT
AT91200354T
patent/ATE109976T1/en
active
1984-01-24
DE
DE3486357T
patent/DE3486357T2/en
not_active
Expired – Fee Related
1984-01-24
EP
EP91200356A
patent/EP0440309B1/en
not_active
Expired – Lifetime
1984-01-24
DE
DE3486338T
patent/DE3486338T2/en
not_active
Expired – Fee Related
1984-01-24
EP
EP84300410A
patent/EP0115419B1/en
not_active
Expired – Lifetime
1984-01-25
AU
AU23765/84A
patent/AU561077B2/en
not_active
Ceased
1984-01-30
IE
IE21284A
patent/IE65028B1/en
not_active
IP Right Cessation
1984-01-31
CA
CA000446497A
patent/CA1227429A/en
not_active
Expired
1984-01-31
DE
DE19843403251
patent/DE3403251A1/en
not_active
Withdrawn
1984-01-31
US
US06/575,744
patent/US4681896A/en
not_active
Expired – Lifetime
1984-01-31
JP
JP59014549A
patent/JPS59152324A/en
active
Pending
1987
1987-05-04
US
US07/045,545
patent/US4806569A/en
not_active
Expired – Fee Related
1989
1989-02-09
US
US07/307,952
patent/US4868212A/en
not_active
Expired – Lifetime
1994
1994-01-06
HK
HK22/94A
patent/HK2294A/en
not_active
IP Right Cessation
1995
1995-03-09
HK
HK32595A
patent/HK32595A/en
not_active
IP Right Cessation
1995-03-09
HK
HK32695A
patent/HK32695A/en
not_active
IP Right Cessation
1995-05-25
HK
HK82595A
patent/HK82595A/en
not_active
IP Right Cessation
1997
1997-03-24
US
US08/823,790
patent/US5763484A/en
not_active
Expired – Fee Related
Cited By (3)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
AU587625B2
(en)
*
1985-07-04
1989-08-24
Scotia Holdings Plc
Pharmaceutical and dietary composition
AU595012B2
(en)
*
1986-03-21
1990-03-22
Scotia Holdings Plc
Iron – containing composition and method for treatment of cancer
AU608571B2
(en)
*
1987-03-09
1991-04-11
Efamol Holdings Plc
Composition and method for treatment of peptic ulcers
Also Published As
Publication number
Publication date
EP0440307A3
(en)
1991-08-28
EP0115419A3
(en)
1985-12-27
CA1227429A
(en)
1987-09-29
DE3486339T2
(en)
1995-01-19
DE3486357D1
(en)
1994-12-15
ATE113836T1
(en)
1994-11-15
ATE109977T1
(en)
1994-09-15
AU2376584A
(en)
1984-08-02
US5763484A
(en)
1998-06-09
DE3486357T2
(en)
1995-05-04
EP0440307A2
(en)
1991-08-07
DE3486338T2
(en)
1995-02-02
US4806569A
(en)
1989-02-21
HK32695A
(en)
1995-03-17
ATE109976T1
(en)
1994-09-15
EP0440307B1
(en)
1994-08-17
US4681896A
(en)
1987-07-21
ATE75143T1
(en)
1992-05-15
IE840212L
(en)
1984-08-01
EP0440309B1
(en)
1994-08-17
IE65028B1
(en)
1995-10-04
DE3486338D1
(en)
1994-09-22
GB8302708D0
(en)
1983-03-02
US4868212A
(en)
1989-09-19
HK32595A
(en)
1995-03-17
HK2294A
(en)
1994-01-14
DE3486339D1
(en)
1994-09-22
EP0115419A2
(en)
1984-08-08
EP0440309A1
(en)
1991-08-07
JPS59152324A
(en)
1984-08-31
EP0115419B1
(en)
1992-04-22
DE3403251A1
(en)
1984-08-02
EP0440308B1
(en)
1994-11-09
EP0440308A1
(en)
1991-08-07
DE3485664D1
(en)
1992-05-27
HK82595A
(en)
1995-06-01
Similar Documents
Publication
Publication Date
Title
AU561077B2
(en)
1987-04-30
Linoleic +alpha-linolenic acids
AU586892B2
(en)
1989-07-27
Pharmaceutical and dietary composition
GB8714772D0
(en)
1987-07-29
Essential fatty acid compositions
DE3571200D1
(en)
1989-08-03
Use of copper and fatty acids
ZA847699B
(en)
1985-08-28
Topical preparations containing tars and fatty acids
AU7018187A
(en)
1987-09-24
Iron – containing composition and method for treatment of cancer
AU554413B2
(en)
1986-08-21
Linoleic acid and essential fatty acid compositions as
AU587625B2
(en)
1989-08-24
Pharmaceutical and dietary composition
DE3161193D1
(en)
1983-11-24
5-aminotetrazole derivatives of retinoic acids, their preparation and pharmaceutical compositions containing them
Legal Events
Date
Code
Title
Description
2002-08-29
MK14
Patent ceased section 143(a) (annual fees not paid) or expired
